ArticleJournal of microbiology and biotechnology2026

Oncogenic GPR161 Drives Melanoma Proliferation and Metabolic Activity through TXNIP Inhibition.

Yuna Roh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.